West Pharmaceutical Services Inc. (WST) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    West Pharmaceutical Servi...

    NYSE: WST · Real-Time Price · USD
    250.86
    3.32 (1.34%)
    At close: Sep 05, 2025, 3:59 PM
    250.00
    -0.34%
    After-hours: Sep 05, 2025, 06:10 PM EDT

    West Pharmaceutical Services Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 484.6M 853.9M 894.3M 762.6M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 202.1M 210M 204.9M 207.7M
    Other Long-Term Assets
    		 74.3M 21.3M 38.4M 55.9M
    Receivables
    		 552.5M 512M 507.4M 489M
    Inventory
    		 377M 434.7M 414.8M 378.4M
    Other Current Assets
    		 124M 135.8M 103M 112M
    Total Current Assets
    		 1.54B 1.94B 1.92B 1.74B
    Property-Plant & Equipment
    		 1.69B 1.51B 1.26B 1.13B
    Goodwill & Intangibles
    		 116.9M 123.6M 125.7M 132.9M
    Total Long-Term Assets
    		 2.11B 1.89B 1.7B 1.57B
    Total Assets
    		 3.64B 3.83B 3.62B 3.31B
    Account Payables
    		 239.3M 242.4M 215.4M 232.2M
    Deferred Revenue
    		 49.6M 41.7M 57.3M 48.7M
    Short-Term Debt
    		 n/a 134M 2.2M 44.2M
    Other Current Liabilities
    		 71.6M 54.2M 54M 45.1M
    Total Current Liabilities
    		 550.4M 671.8M 519M 594.1M
    Long-Term Debt
    		 202.6M 72.8M 206.7M 208.8M
    Other Long-Term Liabilities
    		 105.8M 106.7M 98.9M 107.6M
    Total Long-Term Liabilities
    		 410.7M 276.7M 412.9M 384.3M
    Total Liabilities
    		 961.1M 948.5M 931.9M 978.4M
    Total Debt
    		 302.3M 309M 317.9M 325.3M
    Common Stock
    		 18.8M 18.8M 18.8M 18.8M
    Retained Earnings
    		 3.96B 3.52B 2.99B 2.46B
    Comprehensive Income
    		 -258.1M -143.8M -183M -159.6M
    Shareholders Equity
    		 2.68B 2.88B 2.68B 2.34B
    Total Investments
    		 202.1M 210M 204.9M 207.7M

    Add to Watchlist